Frances Hackman
Impact in
- Virology top 5%
- HIV Research and Treatment
- Pharmacology top 2%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
Papers in
-
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 3
- HIV/AIDS drug development and treatment 3
-
- Allergic Rhinitis and Sensitization 3
- Co-authors
- Sima S. Toussi (3 shared papers)John D. Davis (3 shared papers)Richard Allan (3 shared papers)Sylvester Pawlak (2 shared papers)Gary R. Layton (2 shared papers)Arthur J. Bergman (2 shared papers)Haihong Shi (2 shared papers)Ravi Shankar Prasad Singh (2 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (2 papers)Journal of Allergy and Clinical Immunology (1 paper)Open Forum Infectious Diseases (1 paper)British Journal of Clinical Pharmacology (1 paper)Clinical Therapeutics (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Frances Hackman
12 papers receiving 678 citations
Frances Hackman's Hit Papers
Peers
Comparison fields: 5 of 66
- Virology 92
- Pharmacology 195
- Infectious Diseases 300
- Immunology and Allergy 43
- Emergency Medicine 14
Countries citing papers authored by Frances Hackman
This map shows the geographic impact of Frances Hackman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frances Hackman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frances Hackman more than expected).
Fields of papers citing papers by Frances Hackman
This network shows the impact of papers produced by Frances Hackman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frances Hackman. The network helps show where Frances Hackman may publish in the future.
Co-authors
The 25 scholars most cited alongside Frances Hackman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 231 | |
| 2 | Candidate biomarkers for the diagnosis and prognosis of drug‐induced liver injury: An international collaborative effort Hit paper breakdown → | 2018 | 195 |
| 3 | 2022 | 107 | |
| 4 | 2011 | 48 | |
| 5 | 2009 | 36 | |
| 6 | 2008 | 23 | |
| 7 | 2014 | 20 | |
| 8 | 2022 | 20 | |
| 9 | 2022 | 10 | |
| 10 | 2010 | 7 | |
| 11 | 2023 | 6 | |
| 12 | 2014 | 3 |
About Frances Hackman
Frances Hackman is a scholar working on Infectious Diseases, Immunology and Allergy, Pharmacology, Cardiology and Cardiovascular Medicine and Nuclear Energy and Engineering, having authored 12 papers that have together received 706 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), HIV/AIDS drug development and treatment (3 papers), Allergic Rhinitis and Sensitization (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Drug-Induced Hepatotoxicity and Protection (1 paper) and Cardiac electrophysiology and arrhythmias (1 paper). The work is most often cited by research in Virology (92 citations), Pharmacology (195 citations), Infectious Diseases (300 citations), Immunology and Allergy (43 citations) and Emergency Medicine (14 citations). Frances Hackman has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Sima S. Toussi, John D. Davis, Richard Allan, Sylvester Pawlak, Gary R. Layton, Arthur J. Bergman, Haihong Shi, Ravi Shankar Prasad Singh, Lien Van Eyck and Michael H. Binks. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Journal of Allergy and Clinical Immunology, Open Forum Infectious Diseases, British Journal of Clinical Pharmacology and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.